Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations-Reference-Cited by-同舟云学术

Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations

Published:2015-12 Issue:6 Volume:136 Page:1476-1485
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Teach Stephen J.,Gill Michelle A.,Togias Alkis^ORCID,Sorkness Christine A.,Arbes Samuel J.,Calatroni Agustin,Wildfire Jeremy J.,Gergen Peter J.,Cohen Robyn T.,Pongracic Jacqueline A.,Kercsmar Carolyn M.,Khurana Hershey Gurjit K.,Gruchalla Rebecca S.,Liu Andrew H.,Zoratti Edward M.,Kattan Meyer,Grindle Kristine A.,Gern James E.,Busse William W.,Szefler Stanley J.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference31 articles.

1. Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma–summary report 2007;J Allergy Clin Immunol,2007

2. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial;Szefler;Lancet,2008

3. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children;Busse;N Engl J Med,2011

4. Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma;Ivanova;J Allergy Clin Immunol,2012

5. Severe exacerbations predict excess lung function decline in asthma;Bai;Eur Respir J,2007

Cited by 456 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The new biologic drugs: Which children with asthma should get what?;Pediatric Pulmonology;2024-09-13

2. Pollen and viruses contribute to spatio-temporal variation in asthma-related emergency department visits;Environmental Research;2024-09

3. Type 2 Inflammation and Asthma in Children: A Narrative Review;The Journal of Allergy and Clinical Immunology: In Practice;2024-09

4. Basophil FceRI expression—A management tool in anti‐IgE treatment of allergic asthma;Pediatric Pulmonology;2024-08-07

5. Therapeutic relevance of eosinophilic inflammation and airway viral interactions in severe asthma;Allergy;2024-08